Treatment for early-stage breast cancer is one of the great debates—and now, there’s been incredible progress in understanding whether women diagnosed with stage zero breast cancer, known as ductal ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines in oncology, today announced that Laura J. Esserman, MD ...

The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast ...

Stage 0 cancer, known as carcinoma in situ, marks the earliest stage of cancer development. Abnormal cells are present but ...

Please provide your email address to receive an email when new articles are posted on . Results showed a lower 2-year cumulative rate of invasive ipsilateral breast cancer among patients assigned ...

When 45-year-old Kim Burris was recovering from breast reduction surgery at home in Chapel Hill, she received a call that ...

Stage 0 cancer, or carcinoma in situ, represents the earliest detectable phase where abnormal cells are confined to their ...

Once you know the type of breast cancer you’ve been diagnosed with, you can work with your doctor on a treatment plan that works best for you.

Constance “Connie” Chavis was just 36 when she learned she had stage 3 breast cancer, and Brianna Osofisan was only 21 when diagnosed with triple negative breast cancer. Their journeys reveal the ...

Mar. 24 -- TUESDAY, Feb. 12 (HealthDay News) -- Many women diagnosed with a precancerous breast lesion known as ductal carcinoma in situ (DCIS) are highly anxious about their prognosis, even though ...

There was no significant association between circulating levels of serum 25-hydroxyvitamin D (25[OH]D) and the risk of ductal carcinoma in situ (DCIS) of the breast, either overall or by menopausal ...